U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07672132) titled 'Zinc Supplementation and Inflammation in Older Medical Patients' on May 28.
Brief Summary: The hypothesis is that a daily supplement of 22 mg of zinc over 12 months can reduce in-flammatory biomarkers in acutely hospitalized older adults aged >= 65 years.
The aims are to determine, in acutely hospitalized older adults aged >= 65 years, if a daily supplement of 22 mg of zinc over 12 months compared to control can decrease inflammato-ry biomarkers, reduce symptoms of self-reported infection, reduce readmission and mortali-ty, increase QoL, increase physical performance, investigate potential adverse events to zinc supplement, and the...